Purchase Order 75F40125P00015

This firm-fixed-price purchase order was awarded by the Food and Drug Administration (FDA) to Pacific Biosciences of California, Inc. for preventive maintenance and repair services on a PacBio Sequel II next-generation sequencer. The one-year base period runs from December 12, 2024, to December 11, 2025, with three one-year option periods, for a total potential value of $218,360.00. This award is not set aside for small businesses. Pacific Biosciences is the original equipment manufacturer for the Sequel and Sequel II DNA/RNA sequencing platforms, which are utilized by various federal agencies to support genomic research initiatives. The company holds several IDIQ contracts with the USDA and FDA to provide specialized sequencing equipment, reagents, and support services.